Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4523021
Max Phase: Preclinical
Molecular Formula: C22H20F4N4O4S2
Molecular Weight: 544.55
Molecule Type: Unknown
Associated Items:
ID: ALA4523021
Max Phase: Preclinical
Molecular Formula: C22H20F4N4O4S2
Molecular Weight: 544.55
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CNC(=O)C(c1nc2ccc(-c3ccc(F)nc3)cc2s1)S(=O)(=O)CCC(F)(F)F)NC1CC1
Standard InChI: InChI=1S/C22H20F4N4O4S2/c23-17-6-2-13(10-27-17)12-1-5-15-16(9-12)35-21(30-15)19(36(33,34)8-7-22(24,25)26)20(32)28-11-18(31)29-14-3-4-14/h1-2,5-6,9-10,14,19H,3-4,7-8,11H2,(H,28,32)(H,29,31)
Standard InChI Key: DTLRWTWWBBABSY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 544.55 | Molecular Weight (Monoisotopic): 544.0862 | AlogP: 3.30 | #Rotatable Bonds: 9 |
Polar Surface Area: 118.12 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.44 | CX Basic pKa: | CX LogP: 2.03 | CX LogD: 1.75 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.32 | Np Likeness Score: -1.53 |
1. Kim SH, Johnson JA, Jiang J, Parkhurst B, Phillips M, Pi Z, Qiao JX, Tora G, Ye Chen A, Liu E, Yin X, Yang R, Zhao L, Taylor DS, Basso M, Behnia K, Onorato J, Chen XQ, Abell LM, Lu H, Locke G, Caporuscio C, Adam LP, Gordon D, Wexler RR, Finlay HJ.. (2019) Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase., 29 (15): [PMID:31176700] [10.1016/j.bmcl.2019.05.048] |
Source(1):